<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>RNAi Litigation</title>
	<atom:link href="http://blog.nerac.com/rnailitigation/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.nerac.com/rnailitigation</link>
	<description>(1) Max-Planck, Alnylam v. Whitehead Inst., MIT, Univ. Mass &#38; (2) Tekmira v. Alnylam &#38; (3) Univ. Utah v.  Max-Planck, Alnylam, Whitehead Inst., MIT, Univ. Mass</description>
	<pubDate>Thu, 16 May 2013 21:39:01 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
	<language>en</language>
			<item>
		<title>Cloning of Human Embryonic Stem Cells&#8230;and Human Beings - a Future Platform for Therapeutic RNAi?</title>
		<link>http://blog.nerac.com/rnailitigation/2013/05/16/cloning-of-human-embryonic-stem-cellsand-human-beings-a-future-platform-for-therapeutic-rnai/</link>
		<comments>http://blog.nerac.com/rnailitigation/2013/05/16/cloning-of-human-embryonic-stem-cellsand-human-beings-a-future-platform-for-therapeutic-rnai/#comments</comments>
		<pubDate>Thu, 16 May 2013 13:44:58 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2485</guid>
		<description><![CDATA[We are still waiting for the UUtah case to resume.
Yesterday we read in the NYTimes of a successful cloning of human embryonic stem cells by Oregon Health and Sciences University researchers led by Professor Shoukhrat Mitalipov. This accomplishment was also published yesterday in the acclaimed journal Cell. The synchronous timing of the news release and [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2013/05/16/cloning-of-human-embryonic-stem-cellsand-human-beings-a-future-platform-for-therapeutic-rnai/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Rise of Therapeutic Antibodies – Will RNAi Therapeutics Take As Long?</title>
		<link>http://blog.nerac.com/rnailitigation/2013/04/18/the-rise-of-therapeutic-antibodies-%e2%80%93-will-rnai-therapeutics-take-as-long/</link>
		<comments>http://blog.nerac.com/rnailitigation/2013/04/18/the-rise-of-therapeutic-antibodies-%e2%80%93-will-rnai-therapeutics-take-as-long/#comments</comments>
		<pubDate>Thu, 18 Apr 2013 13:23:22 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2471</guid>
		<description><![CDATA[No, I haven&#8217;t expired.  We are still waiting for the UUtah case to resume after a hiatus of seven months.
NYTimes Obit
When I saw an obit for Hilary Koprowski recently, I was surprised that it did not mention his benchmark work with “monoclonal antibodies” or “hybridomas.” Then I searched Google and found other pages that [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2013/04/18/the-rise-of-therapeutic-antibodies-%e2%80%93-will-rnai-therapeutics-take-as-long/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Motion Granted - Production of the Whitehead Litigation Materials is Stayed</title>
		<link>http://blog.nerac.com/rnailitigation/2013/01/16/motion-granted-production-of-the-whitehead-litigation-materials-is-stayed/</link>
		<comments>http://blog.nerac.com/rnailitigation/2013/01/16/motion-granted-production-of-the-whitehead-litigation-materials-is-stayed/#comments</comments>
		<pubDate>Wed, 16 Jan 2013 15:54:52 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2466</guid>
		<description><![CDATA[
[Case: 12-1540 Document: 70 Page: 2 Filed: 01/03/2013]
Before BRYSON, LINN, and REYNA, Circuit Judges. LINN, Circuit Judge.
O R D E R
The appellants move to stay &#8220;all proceedings&#8221; in the trial court pending disposition of this appeal. The University of Utah opposes. The appellants reply.
The University of Utah sued the appellants concerning the ownership and inventorship [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2013/01/16/motion-granted-production-of-the-whitehead-litigation-materials-is-stayed/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Alnylam/Tekmira Lawsuits ALL Settled - Now On With Alnylam/UUtah</title>
		<link>http://blog.nerac.com/rnailitigation/2012/11/13/alnylamtekmira-lawsuits-all-settled-now-on-with-alnylamuutah/</link>
		<comments>http://blog.nerac.com/rnailitigation/2012/11/13/alnylamtekmira-lawsuits-all-settled-now-on-with-alnylamuutah/#comments</comments>
		<pubDate>Tue, 13 Nov 2012 21:19:51 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2455</guid>
		<description><![CDATA[Alnylam and Tekmira Restructure Relationship and Settle All Litigation
Alnylam to Webcast Conference Call to Discuss Restructuring of Relationship with Tekmira
Tekmira&#8217;s version of the settlement.
Alnylam&#8217;s version of the settlement
Dirk&#8217;s view of the settlement. 

At September 30, 2012, Alnylam had cash, cash equivalents and total marketable securities of $295.8 million not counting more recent deals.
In light of [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2012/11/13/alnylamtekmira-lawsuits-all-settled-now-on-with-alnylamuutah/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Dirk Interprets Alnylam&#8217;s SEC Statement</title>
		<link>http://blog.nerac.com/rnailitigation/2012/11/06/dirk-interprets-alnylams-sec-statement/</link>
		<comments>http://blog.nerac.com/rnailitigation/2012/11/06/dirk-interprets-alnylams-sec-statement/#comments</comments>
		<pubDate>Tue, 06 Nov 2012 22:46:07 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2452</guid>
		<description><![CDATA[See Dirk Haussecker&#8217;s interpretation of Alnylam&#8217;s most recent SEC filing. Settlement not likely.
Dirk says: &#8220;As the trial date approaches, the Company is pursuing all reasonable approaches available to it to reach resolution of this matter, including both settlement negotiations and full trial preparation. The Company does not currently believe that a settlement of this legal [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2012/11/06/dirk-interprets-alnylams-sec-statement/feed/</wfw:commentRss>
		</item>
		<item>
		<title>The Tone of the Infringment Lawsuit Filed by Alnylam and Isis Against Tekmira</title>
		<link>http://blog.nerac.com/rnailitigation/2012/10/26/the-tone-of-the-infringment-lawsuit-filed-by-alnylan-and-isis-against-tekmira/</link>
		<comments>http://blog.nerac.com/rnailitigation/2012/10/26/the-tone-of-the-infringment-lawsuit-filed-by-alnylan-and-isis-against-tekmira/#comments</comments>
		<pubDate>Fri, 26 Oct 2012 18:01:55 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2441</guid>
		<description><![CDATA[[From C.A. NO.: 1:12-CV-10087 RWZ, document 451, filed 10/26/2012]
This is what is going on in the lawsuit filed by Alnylam and Isis Pharmaceuticals against Tekmira for patent infringement.
Plaintiffs Alnylam and Isis Pharmaceuticals respectfully request an extension of two days to present to Defendant Tekmira Pharmaceuticals a written settlement proposal as required by Local Rule 16.1(c). [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2012/10/26/the-tone-of-the-infringment-lawsuit-filed-by-alnylan-and-isis-against-tekmira/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Alnylam&#8217;s Venture into Biopesticides is Not Surprising</title>
		<link>http://blog.nerac.com/rnailitigation/2012/08/29/alnylams-venture-into-biopesticides-is-not-surprising/</link>
		<comments>http://blog.nerac.com/rnailitigation/2012/08/29/alnylams-venture-into-biopesticides-is-not-surprising/#comments</comments>
		<pubDate>Wed, 29 Aug 2012 23:41:26 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2424</guid>
		<description><![CDATA[Monsanto would not do this deal without knowing the outcome of the Tekmira-Alnylam litigation. JL
Donna Ward&#8217;s PCT application that was published in 2011 contains the most broad reaching claims for RNAi, indeed siRNA sprinkled and sprayed on plants, that I have seen in the hundreds of agricultural RNAi patent applications published in the last 12 [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2012/08/29/alnylams-venture-into-biopesticides-is-not-surprising/feed/</wfw:commentRss>
		</item>
		<item>
		<title>How the UUtah Case and the Max-Planck/ Alnylam Case v. Whitehead etal are Connected</title>
		<link>http://blog.nerac.com/rnailitigation/2012/08/27/how-the-uutah-case-and-the-max-planckalnylam-case-v-whitehead-etal-are-connected/</link>
		<comments>http://blog.nerac.com/rnailitigation/2012/08/27/how-the-uutah-case-and-the-max-planckalnylam-case-v-whitehead-etal-are-connected/#comments</comments>
		<pubDate>Mon, 27 Aug 2012 19:49:25 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2421</guid>
		<description><![CDATA[[from Appeal Case: 12-1540 Document: 27-1 Page: 8 Filed: 08/24/2012]
&#8220;(The evidence) can be produced “solely and exclusively” by Alnylam at the press of a button.&#8221;
The University of Utah (“UUtah”), plaintiff in this district court and the Appellee before this Court, opposes Appellants’ so-called Motion to Stay All Proceedings, and respectfully requests that Appellants’ motion be [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2012/08/27/how-the-uutah-case-and-the-max-planckalnylam-case-v-whitehead-etal-are-connected/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Brian Maffly Reports on the Battle for the Rights to siRNA in the Salt Lake Tribune</title>
		<link>http://blog.nerac.com/rnailitigation/2012/08/05/brian-maffly-reports-on-the-battle-for-the-rights-to-sirna-in-the-salt-lake-tribune/</link>
		<comments>http://blog.nerac.com/rnailitigation/2012/08/05/brian-maffly-reports-on-the-battle-for-the-rights-to-sirna-in-the-salt-lake-tribune/#comments</comments>
		<pubDate>Sun, 05 Aug 2012 15:53:30 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2418</guid>
		<description><![CDATA[See Much at stake in University of Utah’s RNA interference lawsuit&#8220;
The link has been fixed. JL
]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2012/08/05/brian-maffly-reports-on-the-battle-for-the-rights-to-sirna-in-the-salt-lake-tribune/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Brief Update on the UUtah Case Against the Four Universities and Alnylam</title>
		<link>http://blog.nerac.com/rnailitigation/2012/08/02/brief-update-on-the-uutah-case-against-the-four-universities-and-alnylam/</link>
		<comments>http://blog.nerac.com/rnailitigation/2012/08/02/brief-update-on-the-uutah-case-against-the-four-universities-and-alnylam/#comments</comments>
		<pubDate>Thu, 02 Aug 2012 18:24:27 +0000</pubDate>
		<dc:creator>johnleavitt</dc:creator>
		
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://blog.nerac.com/rnailitigation/?p=2414</guid>
		<description><![CDATA[Defendants (Max-Planck et. al.) contended in one of their motions to dismiss that Judge Saris&#8217; court does not have jurisdiction over the claims against the UMass state officials because these are barred by UMass&#8217; sovereign immunity. The UMass defendants are Robert L. Caret, President of UMass; James R. Julian, Executive Vice President and Chief Operating [...]]]></description>
		<wfw:commentRss>http://blog.nerac.com/rnailitigation/2012/08/02/brief-update-on-the-uutah-case-against-the-four-universities-and-alnylam/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
